Table 4.
Quality of life score according to the stage of cervical cancer and treatment modalities.
| QLQ Items | Stage | P | Clrel* | Treatment | P | Clrel* | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | II | III | IV | Surgery | S + C + R | C/R | |||||
| N = 103 | N = 119 | N = 20 | N = 14 | N = 60 | N = 137 | N = 59 | |||||
| C30 Functional scales | |||||||||||
| Global health status/ QOL | 70.5 ± 21.8 | 66.1 ± 21.0 | 55.8 ± 24.2 | 33.3 ± 17.9 | 0.000 | Yes | 75.8 ± 18.6 | 66.8 ± 22.9 | 51.1 ± 20.6 | 0.000 | Yes |
| Physical functioning | 87.7 ± 21.8 | 83.5 ± 22.1 | 85.0 ± 20.9 | 66.7 ± 24.4 | 0.003 | Yes | 89.8 ± 16.9 | 83.0 ± 16.0 | 81.6 ± 17.4 | 0.000 | No |
| Role functioning | 87.7 ± 21.8 | 83.5 ± 22.1 | 85.0 ± 20.9 | 66.7 ± 24.4 | 0.003 | Yes | 91.7 ± 16.1 | 82.7 ± 24.0 | 80.8 ± 22.5 | 0.003 | Yes |
| Emotional functioning | 79.5 ± 18.9 | 81.4 ± 16.9 | 80.8 ± 20.2 | 75.0 ± 21.2 | 0.714 | No | 79.4 ± 19.9 | 80.6 ± 17.3 | 80.2 ± 18.6 | 0.991 | No |
| Cognitive functioning | 80.7 ± 17.2 | 79.4 ± 20.5 | 85.0 ± 19.4 | 73.8 ± 22.4 | 0.413 | No | 81.1 ± 19.9 | 78.1 ± 19.2 | 83.6 ± 18.4 | 0.124 | No |
| Social functioning | 76.4 ± 25.3 | 68.9 ± 25.8 | 61.7 ± 31.6 | 59.5 ± 34.4 | 0.034 | Yes | 81.7 ± 21.8 | 70.9 ± 25.6 | 59.6 ± 30.5 | 0.000 | Yes |
| C30 Symptom scales | |||||||||||
| Fatigue | 22.6 ± 21.7 | 24.6 ± 16.4 | 28.9 ± 21.1 | 36.5 ± 22.8 | 0.036 | Yes | 20.4 ± 22.2 | 25.7 ± 19.0 | 27.3 ± 17.3 | 0.014 | No |
| Nausea & vomiting | 9.2 ± 15.2 | 18.3 ± 24.3 | 20.0 ± 25.1 | 28.6 ± 35.5 | 0.009 | Yes | 6.7 ± 16.0 | 14.5 ± 17.8 | 26.3 ± 32.0 | 0.000 | Yes |
| Pain | 15.8 ± 22.4 | 17.9 ± 18.3 | 23.3 ± 20.5 | 21.4 ± 25.7 | 0.166 | No | 11.1 ± 20.9 | 18.4 ± 19.4 | 22.9 ± 21.6 | 0.000 | Yes |
| Dyspnoea | 11.6 ± 18.5 | 15.1 ± 19.8 | 6.7 ± 13.7 | 19.0 ± 25.1 | 0.174 | No | 6.7 ± 16.0 | 16.0 ± 20.2 | 13.6 ± 18.7 | 0.003 | No |
| Insomnia | 31.7 ± 31.1 | 30.2 ± 28.4 | 30.0 ± 23.9 | 42.8 ± 30.4 | 0.446 | No | 25.6 ± 22.4 | 31.6 ± 32.7 | 37.3 ± 26.3 | 0.077 | No |
| Appetite loss | 8.7 ± 18.6 | 19.3 ± 23.1 | 26.7 ± 29.8 | 42.8 ± 40.1 | 0.000 | Yes | 4.4 ± 11.4 | 18.5 ± 25.2 | 25.9 ± 28.4 | 0.000 | Yes |
| Constipation | 19.7 ± 28.2 | 29.4 ± 30.1 | 36.7 ± 32.3 | 33.3 ± 36.9 | 0.016 | Yes | 15.6 ± 28.4 | 27.7 ± 29.0 | 33.9 ± 32.4 | 0.001 | Yes |
| Diarrhoea | 7.8 ± 15.6 | 10.0 ± 16.5 | 16.7 ± 31.5 | 19.0 ± 25.2 | 0.221 | No | 4.4 ± 11.4 | 10.4 ± 18.4 | 15.2 ± 22.6 | 0.006 | Yes |
| Financial difficulties | 41.1 ± 35.6 | 55.2 ± 35.9 | 63.3 ± 35.7 | 80.9 ± 36.3 | 0.000 | Yes | 33.3 ± 36.8 | 54.2 ± 33.6 | 63.8 ± 38.8 | 0.000 | Yes |
| CX24 Functional scales | |||||||||||
| Body image | 22.9 ± 23.9 | 26.0 ± 22.3 | 31.1 ± 25.4 | 24.6 ± 14.6 | 0.286 | No | 22.4 ± 23.5 | 25.1 ± 21.2 | 27.9 ± 25.8 | 0.391 | No |
| Sexual activity | 7.1 ± 15.9 | 8.9 ± 15.5 | 6.7 ± 13.7 | 14.3 ± 17.1 | 0.216 | No | 7.2 ± 16.3 | 8.2 ± 15.0 | 9.6 ± 16.4 | 0.561 | No |
| Sexual enjoyment (n = 80) | 73.0 ± 35.5 | 52.4 ± 50.8 | 83.3 ± 19.2 | 77.8 ± 17.2 | 0.334 | No | 74.5 ± 33.9 | 58.1 ± 47.3 | 69.7 ± 37.9 | 0.429 | No |
| Sexual/vaginal functioning (n = 72) | 75.4 ± 26.2 | 69.7 ± 17.5 | 95.8 ± 4.8 | 83.3 ± 14.9 | 0.054 | No | 85.9 ± 13.9 | 60.0 ± 24.4 | 88.3 ± 13.1 | 0.000 | Yes |
| CX24 Symptom scales | |||||||||||
| Symptom experience | 12.7 ± 9.3 | 15.6 ± 15.1 | 14.2 ± 10.5 | 13.2 ± 9.0 | 0.901 | No | 10.9 ± 7.1 | 14.9 ± 14.0 | 15.7 ± 12.4 | 0.161 | No |
| Lymphoedema | 8.4 ± 20.7 | 8.9 ± 17.2 | 6.7 ± 13.7 | 14.3 ± 25.2 | 0.654 | No | 10.0 ± 21.5 | 8.7 ± 18.6 | 7.9 ± 16.8 | 0.974 | No |
| Peripheral neuropathy | 21.4 ± 21.3 | 24.1 ± 24.9 | 16.7 ± 17.0 | 23.8 ± 40.1 | 0.582 | No | 20.0 ± 23.9 | 23.8 ± 22.8 | 21.5 ± 26.8 | 0.345 | No |
| Menopausal symptoms | 24.6 ± 27.6 | 21.3 ± 22.4 | 13.3 ± 16.7 | 14.3 ± 25.2 | 0.221 | No | 22.2 ± 27.9 | 22.9 ± 23.8 | 18.1 ± 22.6 | 0.400 | No |
| Sexual worry | 16.2 ± 20.3 | 5.0 ± 16.0 | 16.7 ± 31.5 | 4.7 ± 12.1 | 0.000 | Yes | 14.4 ± 16.6 | 8.2 ± 17.5 | 11.3 ± 26.7 | 0.007 | No |
*Clinical relevance ≥10 points differences; S + C + R: surgery + chemotherapy + radiotherapy; C/R: chemotherapy and or radiotherapy.